3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
11
Phase 4
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
134
Neoplasms
112
Polycystic Ovary Syndrome
66
Prostatic Neoplasms
63
Colorectal Neoplasms
51
Carcinoma, Non-Small-Cell Lung
47
Pain
40
Carcinoma, Hepatocellular
35
Lung Neoplasms
34
Keratosis, Actinic
32
Precursor Cell Lymphoblastic Leukemia-Lymphoma
29
Pain, Postoperative
26
Neoplasm Metastasis
26
Head and Neck Neoplasms
26
Stomach Neoplasms
24
Colonic Neoplasms
23
Multiple Myeloma
22
Brain Neoplasms
21
Pancreatic Neoplasms
20
Lymphoma, Follicular
19
Leukemia
19
Anemia
19
Uterine Cervical Neoplasms
18
Leukemia, Myeloid, Acute
18
Infertility
18
Leiomyoma
17
Lymphoma, Non-Hodgkin
16
Lymphoma
16
Cancer Pain
16
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
15
Interventions
palbociclib
1
exemestane
1
Vinorelbine
1
Tamoxifen
1
Paclitaxel
1
Letrozole
1
Fulvestrant
1
Epirubicin
1
Drug Therapy
1
Capecitabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Completed
×
Patient Acceptance of Health Care
×
Clear all
NCT03355157
2024-10-01
PADMA
GBG Forschungs GmbH
Phase 4
Completed
130 enrolled